1. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014; 384 (9959): 2053-63.
2. Auta A, Adewuyi EO, Kureh GT, Onoviran N, Adeloye D. Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis. Vaccine 2018; 36(32): 4851-60.
3. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20(4): 992-1000.
4. Pita I, Horta-Vale AM, Cardoso H, Macedo G. Hepatitis B inactive carriers: An overlooked population? GE Port J Gastroenterol 2014; 21(6): 241-9.
5. Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30(12): 2212-9.
6. David O. White, Frank J. Fenner. Medical Virology 4th ed. Academic Press an Imprint of Elsevier. 1994; pp: 359-379.
7. Kao J-H. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroent 2008; 2(4): 553-62.
8. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 19; 57(8): 1-20.
9. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28(1): 112-25.
10. Salehi-Vaziri M, Sadeghi F, Hashiani AA, Fesharaki MG, Alavian SM. Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis. Hepat Mon 2016; 16(4): e35577
11. Lusida MI, Nugrahaputra VE, Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, et al. Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 2008; 46(7): 2160-6.
12. Almasi-Hashiani A, Ayubi E, Mansori K, Salehi-Vaziri M, Moradi Y, Gholamaliei B, et al. Prevalence of hepatitis B virus infection among Iranian high risk groups: a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench 2018; 11(2): 91-100.
13. Ozer A, Yakupogullari Y, Beytur A, Beytur L, Koroglu M. Risk factors of hepatitis B virus infection in Turkey: A population-based, case-control study: Risk Factors for HBV Infection. Hepat Mon 2011; 11(4): 263-8.
14. Ansari-Moghaddam A, Ostovaneh MR, Mood BS, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon 2012; 12(9): e6618.
15. Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon 2012; 12(2): 112-7.
16. Alavian SM. Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province. Int J Infect 2015; 2(2): e17937.
17. Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of national responsiveness to HBV vaccine after 22 years of Iranian expanded program on immunization (EPI): a systematic review and meta-analysis study. Hepat Mon 2015;15(5): e23618.
18. Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, Shams-Esfandabad K, et al. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in Iran. Hepat Mon 2014; 14(5): e17263.
19. Najafi F, Sayehmiri K, Najafi R. Efficacy of Hepatitis B Vaccination in Under Five-Year-Old Children in Iran: A Systematic Review and Meta-Analysis Study. Hepat Mon 2018; 18(6): e65385.
20. Karajibani M, Roushan MRH, Bayani M, Javanian M, Masrour-Roudsari J. Spontaneous relapse in patients with inactive chronic hepatitis B virus infection. Cas J Int Med 2018; 9(4): 393-6.
21. Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin Liver Dis 2007;11(4):945-63.
22. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol 2010; 58(4): 258-66.
23. Isogawa M1, Tanaka Y. Immunobiology of hepatitis B virus infection. Hepatol Res. 2015; 45 (2):179-89.
24. Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 2010; 138(5): 1747-54.
25. Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018; 68(3):526–549.